他の暗号通貨に移動

NVSNovartis AG

クイックリンク

ポジション計算機

ポジションサイズ (USD)レバレッジ

必要マージン

$10.00

NVS が動いた場合のP&L

+1%+$10.00

+5%+$50.00

+10%+$100.00

レバレッジ{leverage}倍でトレード開始

Novartis AG

NVS

$151.00

+0.00% (24h)

株式ティア Cレバレッジ1000x

重要なポイント

最終更新日時：: 2026-07-06

•ノバルティスは、英国拠点のMyricx Bioを最大15億ドル（ upfront + マイルストーン）で買収することで合意し、2026年下半期の完了を目指す — これは確定した拘束力のある取引である。
•この取引はNMTi-ADC技術を対象としており、抗体薬物複合体（ADC）が製薬業界で最も競争の激しいイノベーションの最前線であることを強化するものである。
•買収者（NVS）は、マイルストーン重視の評価額で早期段階の資産を買収する際に投資家がマイルストーンリスクを評価するため、短期的な売り圧力を受ける可能性がある — 過去の類似取引では短期的な下落が見られた。
•ADCに注力するバイオテック企業は、買収確率の向上と評価倍率の上昇圧力から恩恵を受ける。
•英国のバイオテックのイグジットは、英国の精密オンコロジーエコシステムを裏付け、ロンドン証券取引所に上場するライフサイエンス企業および欧州のヘルスケア指数に若干のポジティブなシグナルを提供する。

価格と市場構造

チャートを読み込んでいます...

取引レジームのステータス

レバレッジ

1000x

(CoinUnited.io最大)

ボラティリティ

N/A

用語集

Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.

Stock CFD	A contract for difference on a share price — price exposure only, not ownership of the underlying shares.
Extended hours	Pre-market and after-hours trading outside the exchange’s regular session.
Basis risk	The risk that the CFD reference price and the exchange execution price do not move in step.
P/E	Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge.
Gross margin	Gross profit ÷ revenue; reflects product-level profitability.
EPS	Earnings per share = net income ÷ diluted shares outstanding.

Get Started with Novartis AG

Start trading Novartis AG on CoinUnited.io with industry-leading leverage and zero fees.

Trade with Leverage

Trade NVS CFDs with up to 1000x leverage on CoinUnited.io.

Up to 1000x leverage
Zero trading fees
Advanced risk management tools

Trade NVS Now

Explore Stocks

Browse the full stocks market on CoinUnited.io with 125+ instruments.

125+ stocks instruments
Real-time market data
Professional charting tools

Browse Stocks

Learn Stocks Trading

Read our in-depth research and analysis on stocks markets.

Expert market analysis
Technical analysis basics
Daily market insights

Read Our Research

How to Trade Novartis AG: Step-by-Step Guide

Learn how to trade Novartis AG (NVS) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.

Create Your CoinUnited.io Account

✓Quick and free registration
✓Email and password setup
✓Two-factor authentication for security

Verify Your Identity

Complete the KYC verification process to unlock full trading features and higher limits.

✓Upload government-issued ID
✓Proof of address document
✓Usually verified within minutes

Deposit Funds

Fund your account using one of the supported deposit methods.

Deposit Methods

•Cryptocurrency deposits (BTC, ETH, USDT)
•Bank transfer available
•No minimum deposit requirement

Find NVS in the Stocks Section

Navigate to the stocks market section and search for NVS. You can trade Novartis AG as a CFD with up to 1000x leverage.

✓Search for "NVS" in the trading platform
✓Select CFD trading mode
✓Review the current price and market data

Place Your Trade

Choose your position direction (long or short), set your leverage, and enter your position size to trade Novartis AG.

✓Long (buy) if you expect NVS to rise
✓Short (sell) if you expect NVS to fall
✓Set stop-loss and take-profit levels

Monitor & Manage Risk

Keep track of your open positions and manage risk with stop-loss orders and position sizing.

✓Monitor P&L in real-time
✓Adjust stop-loss as needed
✓Never risk more than you can afford to lose

Order Types

Market Order

Execute immediately at the current market price. Best for quick entries.

Limit Order

Set a specific price to enter. The order fills only when the market reaches your price.

Stop-Loss Order

Automatically close your position at a specified price to limit potential losses.

Important Tips

• Start with a small position to understand how leverage works
• Always set a stop-loss to protect your capital
• Higher leverage amplifies both gains and losses
• Never invest more than you can afford to lose

Novartis AGの取引準備はできていますか？

最大1000xのレバレッジ

NVSの取引を始めましょう

シンボル

NVS

マーケット

株式

セクター

General

CU商品コード

NVS

Similar Stocks Assets

Explore other stocks instruments in the same sector as Novartis AG. Compare performance and find trading opportunities.

USA Rare Earth, Inc.

$19.24

▲12.4%

Direxion Daily TSLA Bull 2X Shares

$9.79

▲10.1%

MP Materials Corp.

$60.02

▲8.9%

Tempus AI, Inc

$72.73

▲8.8%

ProShares UltraShort Silver

$24.60

▲8.5%

View all General →

著者について

CoinUnited.io Research Team

This Novartis AG page is compiled by CoinUnited.io's research team: analysts covering listed equities and global markets, working from primary filings and named third-party data rather than opinion.

私たちの研究方法論

Every figure is traced to a primary or named third-party source and dated: financial statements from the company’s SEC filings, institutional ownership from Form 13F, analyst targets from aggregated third-party coverage, and market data from the CoinUnited reference price. The Source Map on this page lists each one with its source and the date we last checked it.

Disclaimer: content is for informational and educational purposes only and is not personalized financial advice. A stock CFD carries significant risk and provides price exposure only, not equity ownership. Always conduct your own research and consult a qualified financial advisor.

免責事項および参考文献

重要なリスク免責事項

A CoinUnited stock CFD gives price exposure to Novartis AG only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.

Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.

投資判断を行う前には、利用者ご自身で十分な調査を行い、信頼できる金融専門家に相談することを推奨します。本プラットフォームの作成者および運営者は、提供された情報に依拠したことにより発生した金融損失やその他の損害について、一切の責任を負いかねます。

Leveraged trading is extremely risky and you may lose your entire deposit.

方法論の概要

Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.

Financial statements: the company’s own SEC filings (10-K / 10-Q), read from XBRL
Market data: the CoinUnited reference price and daily closes
Institutional ownership: SEC Form 13F quarterly filings
Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited’s view
Peer multiples: third-party trailing-twelve-month ratios

CoinUnited does not publish a price forecast or target for Novartis AG.

最新の方法論の見直し: